Th17/Treg imbalance modulates rat myocardial fibrosis and heart failure by regulating LOX expression

Min Lu,Xinglei Qin,Jungong Yao,Yuanyuan Yang,Minghu Zhao,Lin Sun
DOI: https://doi.org/10.1111/apha.13537
IF: 7.523
2020-07-30
Acta Physiologica
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aim</h3><p>The imbalance of T helper (Th) 17/ T regulatory (Treg) is involved in chronic heart failure (HF). The enzyme lysyl oxidase (LOX) contributes to myocardial fibrosis. This study was designed to decipher the regulatory mechanism of Th17/Treg on LOX expression and to validate whether Th17/Treg imbalance regulates myocardial fibrosis by modulating LOX expression.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Human cardiac fibroblasts (HCFs) were treated with angiotensin II (Ang II) and co‐cultured with Th17 cells and Tregs which were polarized from control naïve CD4<sup>+</sup> T cells. Th17 cells and Tregs were adoptively transferred into abdominal aortic coarctation‐induced chronic HF rats to investigate the efficacy of Th17 and Treg infusions on myocardial fibrosis and HF. Th17/Treg imbalance (increased Th17 cells and decreased Tregs) was observed in HF patients. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Th17 cells/Tregs aggravated/attenuated Ang II‐induced upregulation of LOX and fibrosis‐related indicators (MMP‐2/9 and collagen I/III) in HCFs <i>in vitro </i> and abdominal aortic coarctation‐induced myocardial fibrosis and HF in rats, by promoting/inhibiting LOX expression. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Mechanistically, Th17 cells promoted LOX expression by activating the IL‐17/ERK1/2‐AP‐1 pathway, while Tregs inhibited LOX expression by activating the IL‐10/JAK1‐STAT3 pathway. Increased Th17 cells and decreased Tregs aggravate myocardial fibrosis and HF by inducing LOX expression.</p></section>
physiology
What problem does this paper attempt to address?